Original story from the Editorial Office of West China School of Stomatology, Sichuan University (Chengdu, China). Researchers uncover a redox-regulated mechanism that determines whether bone fractures heal or progress to non-union. Bone has an extraordinary capacity to heal after injury, restoring its structure and mechanical function without leaving a scar. Yet, for a clinically significant number of patients, this regenerative process fails, resulting in fracture non-union – a condition associated with chronic pain, prolonged disability and repeated surgical interventions. Despite advances in orthopedic techniques, the biological reasons why some fractures fail to heal remain poorly understood. New research now identifies a key molecular mechanism that determines whether bone repair is successfully initiated or derails early in the process. Fracture healing begins immediately after injury, when disrupted blood supply creates a hypoxic microenvironment at the fracture site. This low-oxygen state promotes the production of reactive oxygen species (ROS), which serve as signaling molecules that activate genes required for tissue repair. While tightly regulated ROS signaling is essential for healing, excessive oxidative stress can damage cells and impair regeneration. In this study, researchers identify apurinic/apyrimidinic endonuclease 1 (APEX1), a redox-sensitive protein, as a central mediator that translates hypoxia-driven ROS signals into transcriptional activation required for bone repair. The findings were published on January 16, 2026, in Volume 14 of the journal Bone Research. The study was led by Emma Muiños-López, a researcher at the Instituto de Investigación Sanitaria de Navarra (Pamplona, Spain). Their work focused on understanding how redox biology integrates environmental…
